SCHEMBL30801285

SCHEMBL30801285

c1ccc(COc2ccc(-c3cnc(N4CCCCC4)nc3)c(OCc3ccccc3)n2)cc1

nearest known ligand 0.49

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
HRH4 Q9H3N8 2/20 0.45
CYP11B2 P19099 1/20 0.45
GRM5 P41594 1/20 0.43
GBA1 P04062 1/20 0.38
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
TAAR1 Q96RJ0 1/20 0.38
PDE5A O76074 1/20 0.38
ACHE P22303 1/20 0.38
LMNA P02545 1/20 0.37
HTT P42858 1/20 0.37
AOC3 Q16853 1/20 0.37
ALOX15 P16050 1/20 0.37
TSHR P16473 1/20 0.37
MAPK1 P28482 1/20 0.37
HSD17B10 Q99714 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24671246 0.86 PDE10A (0.40) ALDH1A1SMN1; SMN2HRH4CYP11B2
SCHEMBL29207709 0.86 HRH4 (0.42) ALDH1A1SMN1; SMN2HRH4CYP11B2GRM5
SCHEMBL30066309 0.86 PDE10A (0.40) ALDH1A1SMN1; SMN2HRH4CYP11B2
SCHEMBL25504062 0.85 CNR2 (0.44) ALDH1A1SMN1; SMN2HRH4CYP11B2GRM5
SCHEMBL25200347 0.80 GPR119 (0.40) HRH4GRM5ACHELMNAAOC3
SCHEMBL26077214 0.76 KIT (0.53) ALDH1A1SMN1; SMN2NPC1RAB9ATAAR1
SCHEMBL15953346 0.76 KIT (0.53) ALDH1A1SMN1; SMN2NPC1RAB9ATAAR1
SCHEMBL31374377 0.75 GRM5 (0.41) GRM5PDE5A
SCHEMBL25190595 0.75 GRM5 (0.41) CYP11B2GRM5PDE5A
SCHEMBL38662686 0.75 GRM5 (0.41) CYP11B2GRM5PDE5A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117693502-A Compounds for inhibiting or degrading ITK, compositions comprising the same, methods of making the same, and methods of using the same 纽力克斯治疗公司 2024-03-12 CN disclosed